Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus for congenital vascular malformations
NL-OMON45838Phase 2Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sirolimus in vascular malformation, venous malformation (VM) and lymphangioma, sponsored by Radboud University Medical Center. Started Sep 2017; status: recruiting.
02
Drugs
sirolimus
03
Conditions
vascular malformationvenous malformation (VM)lymphangioma
Beyond the preview
Go deeper on NL-OMON45838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45838.